How confident are you that your next product launch or commercial innovation does not infringe anyone else’s intellectual property rights? The fact that you’re reading this article suggests that you are...
In a predictable blow to those wanting to decrease the costs of international intellectual property litigation, the US Court of Appeals for the Federal Circuit delivered its long-awaited judgment in Voda...
The Zyprexa case is a timely reminder that in IP Strategy, a simple rule of thumb, though useful, is almost always inadequate. Zyprexa underscores the point that infringement and novelty are...
The first-instance judgment in the Australian part of the global Lipitor patent dispute was handed down earlier today (20 December 2006). Click here to go to the judgment. In essence, as...
This one’s succinct but very important for those interested in the interplay between IP strategy and government regulatory control or pharmaceuticals in the USA. The broad take-home is — if government...
In my earlier article ‘Analysing IP — put simply’, I introduced the ‘6T’™ framework for analysing IP issues. This article uses the same framework to show you how to simply structure...
Please use the link to the oxford site to view this article
The ultimate goal in a global IP dispute is rarely to fight and win every case in every country in the world. This is usually a waste of time and money....
The Intellectual Property Laws Amendment Bill (2006) was passed by the Upper House of the Australian Federal Parliament on 14 September 2006. The major amendments are: Exemplary damages for patent infringement...
On 4 September 2006, the Full Court of the Australian Federal Court handed down judgment in Woolworths Limited v BP plc [2006] FCAFC 132. In essence, to establish that a colour...
You must be logged in to post a comment.